These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10522787)

  • 21. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.
    Fernandes AP; Costa MM; Coelho EA; Michalick MS; de Freitas E; Melo MN; Luiz Tafuri W; Resende Dde M; Hermont V; Abrantes Cde F; Gazzinelli RT
    Vaccine; 2008 Oct; 26(46):5888-95. PubMed ID: 18786587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis.
    Talmi-Frank D; Strauss-Ayali D; Jaffe CL; Baneth G
    Clin Vaccine Immunol; 2006 Feb; 13(2):271-6. PubMed ID: 16467337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against Leishmania cross-react with Crithidia luciliae: indirect immunofluorescence and Dot-ELISA study in dogs.
    Martinkovic F; Marinculic A
    Parasitol Res; 2006 Mar; 98(4):378-80. PubMed ID: 16362336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum.
    Molano I; Alonso MG; Mirón C; Redondo E; Requena JM; Soto M; Nieto CG; Alonso C
    Vet Immunol Immunopathol; 2003 Mar; 92(1-2):1-13. PubMed ID: 12628759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
    Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the preservative and temperature conditions on the stability of Leishmania infantum promastigotes antigens applied in a flow cytometry diagnostic method for canine visceral leishmaniasis.
    Gama Ker H; Dian de Oliveira Aguiar-Soares R; Mendes Roatt B; das Dores Moreira N; Coura-Vital W; Martins Carneiro C; Teixeira-Carvalho A; Martins-Filho OA; Cordeiro Giunchetti R; da Silveira-Lemos D; Barbosa Reis A
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):470-6. PubMed ID: 23726649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of specific serologic markers in visceral leishmaniasis: anti-p32 antibody response].
    Tebourski F; Louzir H; Ben Ammar-el Gaied A; Ben Ismaïl R; Dellagi K
    Arch Inst Pasteur Tunis; 1994; 71(3-4):447-51. PubMed ID: 8801840
    [No Abstract]   [Full Text] [Related]  

  • 30. Canine visceral leishmaniasis: a comparative study of real-time PCR, conventional PCR, and direct agglutination on sera for the detection of Leishmania infantum infection.
    Mohammadiha A; Haghighi A; Mohebali M; Mahdian R; Abadi AR; Zarei Z; Yeganeh F; Kazemi B; Taghipour N; Akhoundi B; Barati M; Mahmoudi MR
    Vet Parasitol; 2013 Feb; 192(1-3):83-90. PubMed ID: 23153824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications.
    Cordeiro-da-Silva A; Cardoso L; Araújo N; Castro H; Tomás A; Rodrigues M; Cabral M; Vergnes B; Sereno D; Ouaissi A
    Immunol Lett; 2003 Apr; 86(2):155-62. PubMed ID: 12644317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs.
    Cabral M; O'Grady JE; Gomes S; Sousa JC; Thompson H; Alexander J
    Vet Parasitol; 1998 Apr; 76(3):173-80. PubMed ID: 9615951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Ahmed S; Goldsmith-Pestana K; Nieto J; Osorio Y; Travi B; Moreno J; McMahon-Pratt D
    Vaccine; 2007 Feb; 25(8):1534-43. PubMed ID: 17178178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs.
    Martínez-Orellana P; Quirola-Amores P; Montserrat-Sangrà S; Ordeix L; Llull J; Álvarez-Fernández A; Solano-Gallego L
    Parasit Vectors; 2017 Mar; 10(1):123. PubMed ID: 28288677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy.
    Gonçalves AAM; Leite JC; Resende LA; Mariano RMDS; Silveira P; Melo-Júnior OAO; Ribeiro HS; de Oliveira DS; Soares DF; Santos TAP; Marques AF; Galdino AS; Martins-Filho OA; Dutra WO; da Silveira-Lemos D; Giunchetti RC
    Front Cell Infect Microbiol; 2019; 9():427. PubMed ID: 31921703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection.
    Ramos I; Alonso A; Peris A; Marcen JM; Abengozar MA; Alcolea PJ; Castillo JA; Larraga V
    Vaccine; 2009 Nov; 27(48):6695-703. PubMed ID: 19747996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early antibody response and clinical outcome in experimental canine leishmaniasis.
    Olías-Molero AI; Corral MJ; Jiménez-Antón MD; Alunda JM
    Sci Rep; 2019 Dec; 9(1):18606. PubMed ID: 31819140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Leishmania (Leishmania) infantum excreted-secreted antigens for detection of canine leishmaniasis.
    Pinedo-Cancino V; Laurenti MD; Kesper N; Umezawa ES
    Acta Trop; 2016 Sep; 161():41-3. PubMed ID: 27212707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of the DPP(®) CVL rapid test for canine serodiagnosis in area of visceral leishmaniasis.
    Laurenti MD; de Santana Leandro MV; Tomokane TY; De Lucca HR; Aschar M; Souza CS; Silva RM; Marcondes M; da Matta VL
    Vet Parasitol; 2014 Oct; 205(3-4):444-50. PubMed ID: 25257505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in flow cytometric serology for canine visceral leishmaniasis: diagnostic applications when distinct clinical forms, vaccination and other canine pathogens become a challenge.
    Andrade RA; Silva Araújo MS; Reis AB; Gontijo CM; Vianna LR; Mayrink W; Martins-Filho OA
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):79-86. PubMed ID: 19046772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.